AstraZeneca to Buy Ardea Biosciences for $1.26 Billion

April 23, 2012
AstraZeneca will acquire gout treatment Lesinurad as part of the deal.

Anglo-Swedish drugs giant AstraZeneca PLC (IW 1000/119) on Monday said it had agreed to buy U.S. biotechnology company Ardea Biosciences in a deal worth around $1.26 billion.

"AstraZeneca and Ardea Biosciences, Inc. today announced that they have entered into a definitive merger agreement, pursuant to which AstraZeneca will acquire Ardea, a San Diego, California-based biotechnology company focused on the development of small-molecule therapeutics," a statement said. "Under the terms of the agreement, AstraZeneca will acquire Ardea for $32 per share which represents a total cash value of approximately $1.26 billion."

AstraZeneca added that the price represents a premium of 54% based on Ardea's closing share price last Friday.

Under the deal, AstraZeneca will acquire Lesinurad, a product still in development for the treatment of gout but which it believes has great potential.

"The Ardea team has done a great job developing Lesinurad along with a promising next-generation gout program," AstraZeneca chief executive David Brennan said in the statement.

"These compounds have real potential to benefit patients."

AstraZeneca, which earlier this year announced plans to cut 7,300 jobs by 2014, is seeking new opportunities amid a predicted drop in group earnings this year as patents on some of its key drugs expire.

Copyright Agence France-Presse, 2012

Popular Sponsored Recommendations

What Does Agility Look Like for Today's Auto Industry?

Dec. 4, 2023
Without modern technologies, enterprises aren't able to fully analyze the risks and respond to ongoing supply chain issues and semiconductor shortages.

Electric Vehicles Spark New Opportunities in the Automotive Industry

Dec. 4, 2023
Automakers have increased plans to produce Electric Vehicles to meet customer demand for low emissions. With this radical shift, new opportunities and challenges for the auto ...

Gain a competitive edge with real-world lessons on private 5G networks

Nov. 16, 2023
The use of private networks in manufacturing applications is rapidly growing. In this paper, we present valuable insights and lessons learned from the field with the goal of enhancing...

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!